BR9712633A - Método para o tratamento de infecção por streptococcus pneumoniae - Google Patents

Método para o tratamento de infecção por streptococcus pneumoniae

Info

Publication number
BR9712633A
BR9712633A BR9712633-0A BR9712633A BR9712633A BR 9712633 A BR9712633 A BR 9712633A BR 9712633 A BR9712633 A BR 9712633A BR 9712633 A BR9712633 A BR 9712633A
Authority
BR
Brazil
Prior art keywords
streptococcus pneumoniae
treatment
resistant
methods
pneumoniae infection
Prior art date
Application number
BR9712633-0A
Other languages
English (en)
Inventor
Beth P Goldstein
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of BR9712633A publication Critical patent/BR9712633A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"MéTODO PARA O TRATAMENTO DE INFECçãO POR <MU>STREPTOCOCCUS PNEUMONIAE"<MV><D>. A invenção refere-se a métodos para o aniquilamento de bactérias patogênicas resistentes a antibióticos que ocasionam doença em seres humanos e animais. Particularmente, os métodos dirigem-se ao aniquilamento de cepas bacterianas de Streptococcus pneumoniae resistentes a múltiplas drogas ou resistentes a antibióticos. Os métodos empregam uma lantocina, tal como nisina ou um seu variante como agente bactericida.
BR9712633-0A 1996-10-18 1997-10-14 Método para o tratamento de infecção por streptococcus pneumoniae BR9712633A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2881296P 1996-10-18 1996-10-18
PCT/US1997/018904 WO1998017303A1 (en) 1996-10-18 1997-10-14 A method for the treatment of streptococcus pneumoniae infection

Publications (1)

Publication Number Publication Date
BR9712633A true BR9712633A (pt) 1999-12-21

Family

ID=21845562

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712633-0A BR9712633A (pt) 1996-10-18 1997-10-14 Método para o tratamento de infecção por streptococcus pneumoniae

Country Status (13)

Country Link
US (1) US5910479A (pt)
JP (1) JP2001506976A (pt)
KR (1) KR20000049199A (pt)
CN (1) CN1233186A (pt)
AU (1) AU4909497A (pt)
BR (1) BR9712633A (pt)
CA (1) CA2264794A1 (pt)
HU (1) HUP0000146A2 (pt)
IL (1) IL128849A0 (pt)
NO (1) NO991827D0 (pt)
PL (1) PL332690A1 (pt)
WO (1) WO1998017303A1 (pt)
ZA (1) ZA979110B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
CN1744905A (zh) * 2002-12-10 2006-03-08 百敖新纳斯有限公司 局部抗感染制剂
WO2009141264A2 (en) * 2008-05-20 2009-11-26 Boehringer Ingelheim Vetmedica Gmbh Gallidermin to treat infections of the respiratory tract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4548924A (en) * 1984-04-16 1985-10-22 Eli Lilly And Company Antibiotics M43B and M43C, pharmaceutical composition and method of use
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
GB8811760D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Antibiotic
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
IN167138B (pt) * 1988-08-17 1990-09-01 Hoechst India
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
FR2664894A1 (fr) * 1990-07-19 1992-01-24 Rhone Poulenc Sante Nouveaux derives de streptogramines et leur preparation.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
SK285563B6 (sk) * 1995-06-23 2007-03-01 Ambi, Inc. Použitie lanthocinu na výrobu liečiva na liečenieinfekcie

Also Published As

Publication number Publication date
PL332690A1 (en) 1999-09-27
IL128849A0 (en) 2000-01-31
WO1998017303A1 (en) 1998-04-30
CN1233186A (zh) 1999-10-27
NO991827L (no) 1999-04-16
NO991827D0 (no) 1999-04-16
CA2264794A1 (en) 1998-04-30
ZA979110B (en) 1998-05-11
US5910479A (en) 1999-06-08
AU4909497A (en) 1998-05-15
JP2001506976A (ja) 2001-05-29
HUP0000146A2 (hu) 2000-06-28
KR20000049199A (ko) 2000-07-25

Similar Documents

Publication Publication Date Title
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BR9510423A (pt) Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana
BR0214928A (pt) Fagos isolados e seu uso em produtos alimentares e rações para animais
IL122248A (en) Use of nisin in the manufacture of a medicament for the treatment of an infection and pharmaceutical compositions comprising nisin for said treatment
BR0007166A (pt) Método para aumentar a atividade dos animais de estimação
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
Zubrod et al. Evaluation of arthrocentesis site bacterial flora before and after 4 methods of preparation in horses with and without evidence of skin contamination
ES2133722T3 (es) Utilizacion de dextranos simples o conjugados para la fabricacion de un medicamento para prevenir o reducir el riesgo de infeccion de germenes patogenos bacterianos.
BR9712633A (pt) Método para o tratamento de infecção por streptococcus pneumoniae
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
BR9812066A (pt) Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação
ATE413170T1 (de) Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus
GB2377638B (en) Treatment of infection in animals
BR9800686A (pt) Agente coccidicida e bactericida para aves e suìnos.
Das et al. Successful management of polyarthritis with lincomycin in a calf-A case report
BR0112230A (pt) Anti-helmìnticos para prevenção de infecções parasitárias em seres humanos e animais
ES2076107A1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.
EP1779853A3 (en) 9a-azalides as veterinary antimicrobial agents
TH54568B (th) สารเตรียมทางยาของม็อคซิฟลอซาซิน

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]